Mallick, U <br/><br/>
The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer.  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  Jun 2008 
 - 325-6 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>0936-6555 
<br/><br/><label>Standard No.: </label>10.1016/j.clon.2008.03.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Hormones--administration & dosage<br/>Humans<br/>Iodine Radioisotopes--administration & dosage<br/>Multicenter Studies as Topic<br/>Randomized Controlled Trials as Topic<br/>Thyroid Neoplasms--pathology<br/>Thyroidectomy<br/>Thyrotropin--administration & dosage